# Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study

> **NCT02795845** · NA · COMPLETED · sponsor: **HaEmek Medical Center, Israel** · enrollment: 157 (actual)

## Conditions studied

- Bacterial Vaginosis and Vaginal Candidiasis At Pregnancy

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic Capsule containing L. acidophilus, L. Paracasei, L. Rhamnosus, streptococcus thermophilus and Bifidobacterium bifidum
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02795845
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2021-07
- **Final completion:** 2021-08
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02795845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02795845, "Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02795845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*